Michelle S. Horning

Array ( [id] => 14360179 [patent_doc_number] => 10301377 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-05-28 [patent_title] => Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use [patent_app_type] => utility [patent_app_number] => 15/553466 [patent_app_country] => US [patent_app_date] => 2016-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 56 [patent_no_of_words] => 61368 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 204 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15553466 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10988880 [patent_doc_number] => 20160185826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-30 [patent_title] => 'VIRUS-LIKE PARTICLE VACCINES' [patent_app_type] => utility [patent_app_number] => 15/015249 [patent_app_country] => US [patent_app_date] => 2016-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 20528 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15015249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12247361 [patent_doc_number] => 09920128 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-03-20 [patent_title] => 'Synthetic antiserum for rapid-turnaround therapies' [patent_app_type] => utility [patent_app_number] => 15/001349 [patent_app_country] => US [patent_app_date] => 2016-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6720 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15001349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15355551 [patent_doc_number] => 10526376 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-01-07 [patent_title] => Virus-like particle with efficient epitope display [patent_app_type] => utility [patent_app_number] => 15/542623 [patent_app_country] => US [patent_app_date] => 2016-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 30707 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15542623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12983608 [patent_doc_number] => 20170343530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-30 [patent_title] => LIPID BILAYER-INTEGRATED SPP1 CONNECTOR PROTEIN NANOPORE AND SPP1 CONNECTOR PROTEIN VARIANTS FOR USE AS LIPID BILAYER-INTEGRATED NANOPORE [patent_app_type] => utility [patent_app_number] => 15/543821 [patent_app_country] => US [patent_app_date] => 2016-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26558 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15543821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12199707 [patent_doc_number] => 09902763 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-02-27 [patent_title] => 'Anti-HPV E7 antibodies' [patent_app_type] => utility [patent_app_number] => 14/988981 [patent_app_country] => US [patent_app_date] => 2016-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 11035 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14988981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13699859 [patent_doc_number] => 20170360884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-21 [patent_title] => METHOD FOR TREATING INFLUENZA A VIRUS INFECTION [patent_app_type] => utility [patent_app_number] => 15/537051 [patent_app_country] => US [patent_app_date] => 2015-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5003 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15537051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13011767 [patent_doc_number] => 10028984 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-24 [patent_title] => Clostridium perfringens bacteriophage Clo-PEP-1 and use thereof for inhibiting proliferation of clostridium perfringens [patent_app_type] => utility [patent_app_number] => 15/538252 [patent_app_country] => US [patent_app_date] => 2015-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 4651 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15538252 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10767870 [patent_doc_number] => 20160114026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-28 [patent_title] => 'PAN-LYSSAVIRUS VACCINES AGAINST RABIES' [patent_app_type] => utility [patent_app_number] => 14/978135 [patent_app_country] => US [patent_app_date] => 2015-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17031 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14978135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10755015 [patent_doc_number] => 20160101167 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-14 [patent_title] => 'Composition of Organic Compounds' [patent_app_type] => utility [patent_app_number] => 14/972187 [patent_app_country] => US [patent_app_date] => 2015-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8095 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14972187 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13699953 [patent_doc_number] => 20170360931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-21 [patent_title] => METHODS AND COMPOSITION FOR NEUTRALIZATION OF INFLUENZA [patent_app_type] => utility [patent_app_number] => 15/536857 [patent_app_country] => US [patent_app_date] => 2015-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21978 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -32 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15536857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12029539 [patent_doc_number] => 20170319637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-09 [patent_title] => 'PHAGE THERAPY' [patent_app_type] => utility [patent_app_number] => 15/524271 [patent_app_country] => US [patent_app_date] => 2015-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8518 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15524271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10996374 [patent_doc_number] => 20160193321 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-07 [patent_title] => 'MAKING INFLUENZA VIRUS VACCINES WITHOUT USING EGGS' [patent_app_type] => utility [patent_app_number] => 14/933965 [patent_app_country] => US [patent_app_date] => 2015-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 23833 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14933965 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12542898 [patent_doc_number] => 10010499 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-03 [patent_title] => Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus [patent_app_type] => utility [patent_app_number] => 14/930831 [patent_app_country] => US [patent_app_date] => 2015-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 13535 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14930831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12549147 [patent_doc_number] => 10012594 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-03 [patent_title] => Coliphage biosensor [patent_app_type] => utility [patent_app_number] => 14/929600 [patent_app_country] => US [patent_app_date] => 2015-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 3921 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14929600 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15381897 [patent_doc_number] => 10532107 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-01-14 [patent_title] => Modified virus-like particles of CMV [patent_app_type] => utility [patent_app_number] => 15/520676 [patent_app_country] => US [patent_app_date] => 2015-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 25 [patent_no_of_words] => 31796 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15520676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12470076 [patent_doc_number] => 09988608 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2018-06-05 [patent_title] => Methods of expanding bacteriophage host-range and bacteriophage produced by the methods [patent_app_type] => utility [patent_app_number] => 14/883366 [patent_app_country] => US [patent_app_date] => 2015-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 43 [patent_no_of_words] => 11597 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14883366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17975751 [patent_doc_number] => 11492601 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-08 [patent_title] => Multiple host range bacteriophage with hybrid tail fibres [patent_app_type] => utility [patent_app_number] => 15/517664 [patent_app_country] => US [patent_app_date] => 2015-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 48 [patent_no_of_words] => 15295 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15517664 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11993964 [patent_doc_number] => 20170298120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-19 [patent_title] => 'ANTIBODIES THAT BIND EBOLA GLYCOPROTEIN AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/515746 [patent_app_country] => US [patent_app_date] => 2015-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 39777 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15515746 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11018069 [patent_doc_number] => 20160215023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-28 [patent_title] => 'SIMPLE VACCINES FROM DNA LAUNCHED SUICIDAL FLAVIVIRUSES' [patent_app_type] => utility [patent_app_number] => 14/870759 [patent_app_country] => US [patent_app_date] => 2015-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 23629 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14870759 [rel_patent_id] =>[rel_patent_doc_number] =>)